Moderna, Pfizer Get Tough Dose Of Medicine


Moderna (NASDAQ:) has experienced a wipeout of nearly 75% in just six months. I’m sure the insiders dumped at just the right time and left the retail bag-holders wondering what just happened with their “investment.”

Moderna Chart.

Pfizer (NYSE:) is actually not doing so hot, either, even though it has shameless taken hundreds of billions of government bucks.

Pfizer Chart.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

Comments are closed, but trackbacks and pingbacks are open.